Clinical Trial

China Monogenic Diabetes Registry

Study acronym: CMDR
Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis
Trial Details
NCT Number NCT07492004
Lead Sponsor Tianjin Medical University General Hospital
Conditions Neonatal Diabetes, Monogenic Diabetes, Maturity Onset Diabetes of the Young
Enrollment 5,000 participants
Start Date 2021-02-28
Primary Completion 2030-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-25